This site is intended for healthcare professionals only
LoginRegister
Roche Drops Muscle Disease Drug After Trial FailureUSFDA nod to Roche Gazyva/Gazyvaro for lupus nephritis
JnJ completes acquisition of Halda Therapeutics, its novel platform for cancer treatmentTorrent Pharma finally gets CCI nod for acquisition of JB Chemicals
Alembic Launches First Branded Drug Pivya in US for UTI TreatmentAlembic Pharma gets USFDA okay for Triamcinolone Acetonide Injectable Suspension
Granules India packaging facility in US successfully completes USFDA inspectionDr Reddy's Labs Srikakulam facility gets EIR from USFDA
Aurobindo Pharma arm to acquire 20% additional ownership in Luoxin Aurovitas for Rs 45 croreAbbVie concludes acquisition of Gilgamesh Pharma Bretisilocin
Syngene International, Bristol Myers Squibb Extend Strategic Collaboration Through 2035Syngene International invests in peptide lab, advanced automation
Biocon Biologics Secures BB+ Rating Upgrade from S&P on Improved Financial MetricsBiocon Told to Submit Detailed Toxicity, SAE Data on Semaglutide Prefilled Pen After Animal Deaths
Junior residents salary counts as income to determine exclusion from EWS quota: Delhi HCAlkem Vs Alchem: Delhi HC Grants Interim Relief to Alkem Labs in Trademark Tussle
Eli Lilly in Talks to Acquire Ventyx Biosciences in USD 1 Billion-Plus DealCDSCO Panel Clears Eli Lilly's Tirzepatide for Phase IV Clinical Trial in India
USFDA Flags Compliance Issues at Novo Nordisks New Jersey FacilityNovo Nordisk inks pact with Omeros for clinical-stage MASP-3 inhibitor zaltenibart
USFDA Grants Fast-Track Nod to Boehringer Ingelheims Zongertinib for Rare Lung CancerBoehringer Ingelheim, AimedBio collaborate to develop ADC therapy for cancer
CDSCO Panel Opines Key Changes in Phase III Study of Glimepiride-Linagliptin FDCCDSCO Panel Rejects Pure and Cure's Empagliflozin-Based FDC, Flags Risk of UTI, Genital Mycosis
X